Monistat 3 en es it fr

Monistat 3 Brand names, Monistat 3 Analogs

Monistat 3 Brand Names Mixture

  • No information avaliable

Monistat 3 Chemical_Formula


Monistat 3 RX_link

Monistat 3 fda sheet

Monistat 3 msds (material safety sheet)

Monistat 3 Synthesis Reference

No information avaliable

Monistat 3 Molecular Weight

498.568 g/mol

Monistat 3 Melting Point

No information avaliable

Monistat 3 H2O Solubility

Soluble (about 10% weight-to-volume) in distilled water at room temperature as HCl salt.

Monistat 3 State


Monistat 3 LogP


Monistat 3 Dosage Forms

Tablets (scored, coated, containing 7.5 mg or 15 mg of moexipril hydrochloride for oral administration)

Monistat 3 Indication

For treatment of patients with hypertension.

Monistat 3 Pharmacology

Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. It is used to treat high blood pressure (hypertension). It works by relaxing blood vessels, causing them to widen. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems.

Monistat 3 Absorption

Moexipril is incompletely absorbed, with bioavailability as moexiprilat of about 13% compared to intravenous (I.V.) moexipril (both measuring the metabolite moexiprilat), and is markedly affected by food, which reduces Cmax and AUC by about 70% and 40% respectively after the ingestion of a low-fat breakfast or by 80% and 50% respectively after the ingestion of a high-fat breakfast.

Monistat 3 side effects and Toxicity

Human overdoses of moexipril have not been reported. In case reports of overdoses with other ACE inhibitors, hypotension has been the principal adverse effect noted. Single oral doses of 2 g/kg moexipril were associated with significant lethality in mice. Rats, however, tolerated single oral doses of up to 3 g/kg.

Monistat 3 Patient Information

Monistat 3 Organisms Affected

Humans and other mammals